Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
96.650,48
0,19%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Shield Therapeutics Plc (STX) Shield Therapeutics Plc (STX) Notizie

Shield Therapeutics Plc

STX
3,00
-0,10 (-3,23%)
07 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
05/2/202517:30ALNCNewsShield Therapeutics shares surge as revenue up on..
05/2/202508:00LSEG_RNSShield Therapeutics PLC Unaudited full year trading update
28/1/202514:43ALNCNewsEXECUTIVE CHANGES: Smithson changes chairs; British Land..
27/1/202508:00LSEG_RNSShield Therapeutics PLC Anders Lundstrom appointed CEO
24/12/202412:25LSEG_RNSShield Therapeutics PLC Result of General Meeting & Total..
23/12/202408:00LSEG_RNSShield Therapeutics PLC Results of RetailBook Offer
06/12/202415:35ALNCNewsShield Therapeutics to raise USD10.0 million via AOP..
06/12/202412:31LSEG_RNSShield Therapeutics PLC RetailBook Offer
06/12/202412:30LSEG_RNSShield Therapeutics PLC Subscription by AOP Health to raise..
21/11/202415:22ALNCNewsShield Therapeutics shares up on strong October sales
21/11/202408:00LSEG_RNSShield Therapeutics PLC Business Update
29/10/202415:34ALNCNewsShield Therapeutics shares slide as it expands financing..
29/10/202408:00LSEG_RNSShield Therapeutics PLC Q3 Trading Update
25/9/202408:00LSEG_RNSShield Therapeutics PLC Results from Phase 3 paediatric..
04/9/202412:39ALNCNewsShield Therapeutics revenue triples, but cost rises widen..
04/9/202408:00LSEG_RNSShield Therapeutics PLC Interim results
27/8/202420:34ALNCNewsTRADING UPDATES: Shield Therapeutics lands Canada win; RUA..
27/8/202408:00LSEG_RNSShield Therapeutics PLC ACCRUFeR® Approved by Health Canada
14/8/202408:00LSEG_RNSShield Therapeutics PLC Notice of interim results
26/7/202416:27ALNCNewsEXECUTIVE CHANGES: Morgan Advanced Materials picks senior..
24/7/202408:01LSEG_RNSShield Therapeutics PLC Unaudited Q2 2024 Trading Update
24/7/202408:00LSEG_RNSShield Therapeutics PLC Directorate Change
03/7/202417:26ALNCNewsEARNINGS AND TRADING: ActiveOps makes profit; Contango gets..
03/7/202408:00LSEG_RNSShield Therapeutics PLC $5.7m Milestone Monetization..
20/6/202417:25LSEG_RNSShield Therapeutics PLC Results of 2024 Annual General..
28/5/202421:32ALNCNewsTRADING UPDATES: NetScientific backs Wanda; Inspirit Energy..
28/5/202408:00LSEG_RNSShield Therapeutics PLC New Drug Application for Accrufer®..
10/5/202416:30LSEG_RNSShield Therapeutics PLC Audited results for the year ended..
30/4/202420:54ALNCNewsEARNINGS AND TRADING: Software Circle & Beximco report..
30/4/202408:00LSEG_RNSShield Therapeutics PLC Business Update for Q1 2024
16/4/202408:00LSEG_RNSShield Therapeutics PLC Notice of Results
21/2/202413:36ALNCNewsShield Therapeutics sinks as strong performance marred by..
21/2/202408:00LSEG_RNSShield Therapeutics PLC Unaudited Full Year Trading Update
Apertura: 3,10 Min: 2,95 Max: 3,15
Chiusura: 3,10

La tua Cronologia

LSE
STX
Shield Therapeutics
BIT
UC86DH
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci